15% off first order with code: 1storder
Tirzepatide, developed by Pharma Lab Global AFRICA, is an innovative and synthetic dual GIP and GLP-1 receptor agonist. It mimics the biological activity of native glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), by interacting with their respective receptors.
This unique characteristic opens up new avenues for exploring the functions of these peptides in various physiological processes. It holds immense promise in uncovering potential therapeutic pathways for conditions such as diabetes and obesity. Available as a peptide vial, Tirzepatide from Pharma Lab Global AFRICA offers flexibility and ease of use for diversified research explorations.
Showing the single result
ALL PRODUCTS AVAILABLE ON THIS WEBSITE ARE FOR RESEARCH PURPOSES ONLY.
DISCLAIMER: All products on this site https://africa.pharmalabglobal.com are exclusively for research and laboratory purposes only. The products on this site are not intended for use in humans or animals, nor are they designed to diagnose, treat, cure or prevent any illness. All information and content provided on our Pharma Lab Global website are purely for educational purposes. All products are to be handled by suitably qualified and properly trained research professionals only.